IMCLONE SYSTEMS INCORPORATED has a total of 11 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, Tunisia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are IMMUNOTECH DEV INC, HANGZHOU SUMGEN BIOTECH CO LTD and ABBVIE BIOTHERAPEUTICS INC.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Preservation of human bodies | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Moore Jeffrey G | 2 |
#2 | Goldstein Neil I | 2 |
#3 | Zhu Zhenping | 2 |
#4 | Rowinsky Eric | 1 |
#5 | Teufel Thomas | 1 |
#6 | Srivastava Arvind | 1 |
#7 | Goldstein Joel | 1 |
#8 | Colucci M Gabriella | 1 |
#9 | Rockwell Patricia | 1 |
#10 | Liu Meilin | 1 |
Publication | Filing date | Title |
---|---|---|
CA2560305A1 | Human anti-epidermal growth factor receptor antibody | |
AU2003213697A1 | Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist | |
AU2001295002B2 | Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |